28Mar 2018

THE SKIN BARRIER FUNCTION AND THE DEVELOPMENT OF DERMATITIS.

  • Internal medicine department, Al Adan hospital, Al Ahmadi hospital, Kuwait.
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

The skin barrier is a very important element of the body as it plays crucial roles in the immune surveillance and epidermal homeostasis, and in stopping entrance of microorganisms and allergens. The capacity of the skin to protect the body relies on its structure that includes different layers of cells containing components such proteins and lipids organized in such a way that they provide a tight and strong structure to the skin. Due to various factors, impairments of the structural integrity of the skin occur and compromise its barrier functions provoking thereby immune responses that lead to inflammatory reactions responsible for skin diseases such as dermatitis. According to the causative agent, the location and the symptoms, different types of dermatitis can be identified. These include for example allergic contact dermatitis, atopic dermatitis known as eczema, seborrheic dermatitis and nummular dermatitis. Common symptoms are associated with dry and itchy skin accompanied by the occurrence of blisters. Both genetics and environmental factors play a role in the occurrence of dermatitis. The genetic factors include mutations in genes coding for important skin proteins such as filaggrin responsible for different functions mainly in relation to water retention. Environmental factors can be associated with allergens, detergent, surfactant, excessive washing and exfoliation, and inappropriate diet. This research paper provides an overview of the occurrence of dermatitis in relation to defects in the skin barrier function. Different types of dermatitis, the normal skin structure components, and its associated functions are discussed. Moreover, the basis for structural defects in the skin in relation to mainly atopic dermatitis, with an emphasis on filaggrin and its genetic underpinnings are reviewed. Aspects of the innate and adaptive immunity, including the role of anti-microbial peptides and proteases are also depicted.


  1. Agrawal, R. and Woodfolk, J. (2014). Skin Barrier Defects in Atopic Dermatitis. Current Allergy and Asthma Reports, 14(5), pp.1-20.
  2. Ananthapadmanabhan, K., Moore, D., Subramanyan, K., Misra, M. and Meyer, F. (2004). Cleansing without compromise: the impact of cleansers on the skin barrier and the technology of mild cleansing. Dermatologic Therapy, 17(s1), pp.16-25.
  3. Cork, M., Danby, S., Vasilopoulos, Y., Hadgraft, J., Lane, M., Moustafa, M., Guy, R., MacGowan, A., Tazi-Ahnini, R. and Ward, S. (2009). Epidermal Barrier Dysfunction in Atopic Dermatitis. Journal of Investigative Dermatology, 129(8), pp.1892-1908.
  4. Cowley, N.C. and Farr, P.M. (1992). A dose-response study of irritant reactions to sodium lauryl sulphate in patients with seborrhoeic dermatitis and atopic eczema. Acta Dermato Venereologica, 72, pp.432-435.
  5. De Benedetto, A., Agnihothri, R., McGirt, L., Bankova, L. and Beck, L. (2009). Atopic Dermatitis: A Disease Caused by Innate Immune Defects?. Journal of Investigative Dermatology, 129(1), pp.14-30.
  6. Deleuran, Anne Ringer Ellingsen, Ki, M. (1998). Purified Der p1 and p2 Patch Tests in Patients with Atopic Dermatitis: Evidence for Both Allergenicity and Proteolytic Irritancy: Investigative Reports. Acta Dermato-Venereologica, 78(4), pp.241-243.
  7. Elias, P.M. and Williams, M.L. (2018). What is the Skin Barrier and Why Does it Matter?. [online] Elias and Williams. Available at: http://eliasandwilliams.com/skin-barrier/ [Accessed 16 Feb. 2018].
  8. Irvine, A., McLean, W. and Leung, D. (2011). Filaggrin Mutations Associated with Skin and Allergic Diseases. New England Journal of Medicine, 365(14), pp.1315-1327.
  9. Jeong, S., Kim, H., Youm, J., Ahn, S., Choi, E., Sohn, M., Kim, K., Hong, J., Shin, D. and Lee, S. (2008). Mite and Cockroach Allergens Activate Protease-Activated Receptor 2 and Delay Epidermal Permeability Barrier Recovery. Journal of Investigative Dermatology, 128(8), pp.1930-1939.
  10. Leung, D. (2013). New Insights into Atopic Dermatitis: Role of Skin Barrier and Immune Dysregulation. Allergology International, 62(2), pp.151-161.
  11. Mayo Clinic. (2018). Dermatitis - Symptoms and causes. [online] Available at: https://www.mayoclinic.org/diseases-conditions/dermatitis-eczema/symptoms-causes/syc-20352380 [Accessed 15 Feb. 2018].
  12. Millward, A. (2018). The Important Role Of Skin Barrier Function - Andy Millward - Facialist. [online] Andy Millward - Facialist. Available at: https://andymillward-skincare.co.uk/2015/09/the-important-role-of-skin-barrier-function/ [Accessed 16 Feb. 2018].
  13. Nemoto-Hasebe, I., Akiyama, M., Nomura, T., Sandilands, A., Irwin McLean, W. and Shimizu, H. (2009). Clinical Severity Correlates with Impaired Barrier in Filaggrin-Related Eczema. Journal of Investigative Dermatology, 129(3), pp.682-689.
  14. Silverberg, J. and Hanifin, J. (2013). Adult eczema prevalence and associations with asthma and?other health and demographic factors: A?US population?based study. Journal of Allergy and Clinical Immunology, 132(5), pp.1132-1138.
  15. Spergel, J. (2010). Epidemiology of Atopic Dermatitis and Atopic March in Children. Immunology and Allergy Clinics of North America, 30(3), pp.269-280.
  16. Palmer, C., Irvine, A., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S., Goudie, D., Sandilands, A., Campbell, L., Smith, F., O'Regan, G., Watson, R., Cecil, J., Bale, S., Compton, J., DiGiovanna, J., Fleckman, P., Lewis-Jones, S., Arseculeratne, G., Sergeant, A., Munro, C., El Houate, B., McElreavey, K., Halkjaer, L., Bisgaard, H., Mukhopadhyay, S. and McLean, W. (2006). Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nature Genetics, 38(4), pp.441-446.
  17. Proksch, E., Brandner, J. and Jensen, J. (2008). The skin: an indispensable barrier. Experimental Dermatology, 17(12), pp.1063-1072.
  18. Purvis, D., Thompson, J., Clark, P., Robinson, E., Black, P., Wild, C. and Mitchell, E. (2005). Risk factors for atopic dermatitis in New Zealand children at 3.5 years of age. British Journal of Dermatology, 152(4), pp.742-749.
  19. Thawer-Esmail, F. (2011). Skin Barrier function and atopic eczema. Current Allergy & Clinical Immunology, 24(4), pp. 193-198.
  20. Thomsen, S.F. (2014). Atopic Dermatitis: Natural History, Diagnosis, and Treatment. ISRN Allergy, 2014, pp.1-7.
  21. (2018). What is dermatitis. [Online] Available at: https://www.webmd.com/skin-problems-and-treatments/guide/understanding-dermatitis-basics#1[Accessed 15 Feb. 2018].
  22. Winton, H., Wan, H., Cannell, M., Thompson, P., Garrod, D., Stewart, G. and Robinson, C. (1998). Class specific inhibition of house dust mite proteinases which cleave cell adhesion, induce cell death and which increase the permeability of lung epithelium. British Journal of Pharmacology, 124(6), pp.1048-1059.

[Mohammad fm fr alajmi. (2018); THE SKIN BARRIER FUNCTION AND THE DEVELOPMENT OF DERMATITIS. Int. J. of Adv. Res. 6 (Mar). 1207-1214] (ISSN 2320-5407). www.journalijar.com


MOHAMMAD F M F R ALAJMI
Internal medicine department, Al Adan hospital, Al Ahmadi hospital, Kuwait

DOI:


Article DOI: 10.21474/IJAR01/6786      
DOI URL: https://dx.doi.org/10.21474/IJAR01/6786